equityflowunderstand the flow and follow it
EquityFlow › Companies › Concinnity Genetics

Concinnity Genetics

biotech · Edinburgh, GB

Edinburgh gene-control company designing RNA-based safety systems for gene therapies.

In the network

Shares the most investors with (number = shared investors):
Carcinotech 3BIOCAPTIVA 2Chromacity 2Nami Surgical 2Waire Health 2

Funding history

DateRoundAmount
Dec 2024Seed
Edinburgh spinout Concinnity Genetics raised 3M GBP seed led by Eos Advisory to develop AI-driven gene-therapy control systems.
$3.8M

Investors

Tap an investor to see what else they have backed.

Eos AdvisoryMaven Capital PartnersOld College CapitalScottish Enterprise

Other companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIACarboCode

Other companies in GB

Capsa AI01HealthRem3dy HealthNewOrbitJoyvié HealthFuse EnergyAirspeedSembleWordsmithOxford Quantum CircuitsFreshaImperagen

Other companies at Seed stage

&Open(Re)vive1-2-Taste100% Livre1000 Satellites100ms10club10pct.10x Science10x.team123Projetei150 Minuten
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.